International Guidelines — WHO, IOF, and NOF Recommendations Explained

• How osteoporosis is diagnosed using the WHO criteria
• How fracture risk is assessed (FRAX and beyond)
• What the major guidelines (IOF, NOF, AACE, NICE, RACGP) recommend for treatment
• The shift from "treat the T-score" to "treat the fracture risk"
• Key consensus points that all guidelines agree on
• What these guidelines mean for you as a patient

The World Health Organization (WHO) established the diagnostic criteria for osteoporosis that are used worldwide. The key measure is your T-score, obtained from a DEXA (bone density) scan.

Important to understand: A T-score compares your bone density to that of a healthy 30-year-old adult. A score of -2.5 means your bone density is 2.5 standard deviations below the young adult average.

But here is what modern guidelines emphasize: your T-score is only part of the story. Treatment decisions are increasingly based on your overall fracture risk, not just your bone density number.

FRAX: The fracture risk calculator

The FRAX tool (Fracture Risk Assessment Tool), developed by the WHO, estimates your 10-year probability of a major osteoporotic fracture (hip, spine, shoulder, or wrist) and your 10-year probability of hip fracture specifically.

FRAX considers:

• Your age and sex
• Body mass index (BMI)
• Prior fracture history
• Parental history of hip fracture
• Current smoking
• Glucocorticoid use (prednisone or similar)
• Rheumatoid arthritis
• Secondary causes of osteoporosis
• Alcohol intake (3 or more units per day)
• Bone mineral density at the femoral neck (if available)

How FRAX is used in treatment decisions:

In the United States, the NOF recommends treatment when:

• FRAX 10-year probability of major osteoporotic fracture is 20% or higher, OR
• FRAX 10-year probability of hip fracture is 3% or higher
• (In addition to anyone with a T-score of -2.5 or below, or anyone who has already had a hip or vertebral fracture)

In the United Kingdom, the NOGG (National Osteoporosis Guideline Group) uses FRAX with country-specific thresholds to determine treatment recommendations.

FRAX is available free online and your doctor can calculate it for you. It helps move the conversation from "what is my bone density?" to the more important question: "what is my fracture risk?"

While guidelines from different organizations are not identical, they share a strong core of agreement. Here is an overview of the most influential frameworks:

NOF (National Osteoporosis Foundation, USA)

The NOF Clinician's Guide recommends treatment for postmenopausal women and men aged 50 and older who have:

• A hip or vertebral fracture
• A T-score of -2.5 or below at the spine, femoral neck, or total hip
• A T-score between -1.0 and -2.5 with a FRAX 10-year probability meeting the thresholds above

AACE/ACE (American Association of Clinical Endocrinology)

The AACE 2020 guidelines introduced a risk-stratification approach that is particularly useful:

This risk-stratified approach represents a significant advance — it ensures that the most powerful treatments (bone-building medications) are directed to the patients who need them most.

IOF/ESCEO (International Osteoporosis Foundation / European Society for Clinical and Economic Aspects of Osteoporosis)

The IOF/ESCEO 2019 guidelines emphasize:

• Using FRAX for treatment decisions
• The concept of imminent fracture risk (highest risk in the first 2 years after a fracture)
• Sequential therapy for very high-risk patients
• The importance of Fracture Liaison Services (FLS)

NICE (National Institute for Health and Care Excellence, UK)

NICE provides technology appraisals for specific medications and works with the NOGG guideline:

• Uses FRAX with UK-specific thresholds
• Recommends bone-protective treatments based on fracture probability and T-score
• Has approved romosozumab for severe postmenopausal osteoporosis
• Emphasizes cost-effectiveness in treatment selection

RACGP (Royal Australian College of General Practitioners)

The Australian guidelines:

• Use FRAX with Australian-specific thresholds
• Recommend treatment for patients with minimal trauma fractures
• Emphasize the role of GPs (general practitioners) in osteoporosis management
• Provide practical guidance for the primary care setting

Despite differences in specific thresholds and recommendations, there is remarkable consensus on the following principles:

1. Treat fracture risk, not just T-scores

Modern osteoporosis care has moved beyond simply looking at your bone density number. A T-score of -2.6 with no other risk factors is very different from a T-score of -2.6 in someone who has already had a fracture, takes steroids, and has a family history of hip fracture. Guidelines increasingly emphasize treating the whole picture of fracture risk.

2. Sequential therapy for very high-risk patients

All major guidelines now recognize that for patients at the highest risk of fracture, starting with a bone-building medication (anabolic therapy) and then switching to a bone-protecting medication produces better outcomes than starting with a bone-protector alone.

3. Long-term management — not "take a pill and forget"

Osteoporosis is a chronic condition that requires ongoing attention:

• Medication may need to be adjusted over time
• Bone density monitoring helps guide decisions
• Drug holidays may be appropriate for bisphosphonates, but not for all medications
• Stopping certain medications (especially denosumab) requires careful planning

4. Calcium and vitamin D as the foundation

Every guideline recommends ensuring adequate calcium and vitamin D intake as the foundation of bone health:

• Calcium: 1,000 to 1,200 mg per day (preferably from food; supplements if needed)
• Vitamin D: 800 to 2,000 IU per day (your doctor may recommend more based on blood levels)
• These are not substitutes for medication in patients who need it — they are the foundation on which medication works

5. Fall prevention as part of fracture prevention

A fracture requires two things: weak bones AND a force applied to them (usually a fall). All guidelines emphasize that preventing falls is just as important as strengthening bones:

• Balance and strength exercises
• Home safety modifications
• Vision and hearing checks
• Medication review for drugs that cause dizziness
• Proper footwear

6. Post-fracture care is critical

Every guideline body has recognized the fracture treatment gap — the failure to assess and treat osteoporosis after a fracture. Programs like the IOF's Capture the Fracture and Fracture Liaison Services are designed to ensure that anyone who fractures gets appropriate bone assessment and treatment.

United States

• NOF and AACE/ACE are the primary guidelines
• Medicare covers DEXA scans every 2 years for women 65+ and others at risk
• Insurance coverage for osteoporosis medications varies — your doctor can help with prior authorization
• Generic bisphosphonates are widely available and affordable

United Kingdom

• NOGG and NICE guide clinical practice
• NICE technology appraisals determine which treatments are available through the NHS
• FRAX with UK-specific thresholds is used for treatment decisions
• FLS programs are well-established in many hospitals

Australia

• RACGP guidelines are widely used in primary care
• The Pharmaceutical Benefits Scheme (PBS) subsidizes osteoporosis medications for eligible patients
• FRAX with Australian thresholds helps guide treatment decisions
• "Bone health programs" in many hospitals provide post-fracture care

You do not need to memorize guideline details. What matters is understanding the principles that guide your care:

1. Your treatment should be based on your overall fracture risk — not just one number
2. If you have had a fracture, you deserve prompt bone assessment and treatment
3. More powerful treatments exist for those at the highest risk — do not settle for "wait and see" if your risk is high
4. Treatment is a long-term partnership between you and your doctor
5. Medication works best when combined with calcium, vitamin D, exercise, and fall prevention
6. You have the right to ask questions — "What is my fracture risk?" "Why this medication?" "What are my options?"

• Ask your doctor about your FRAX score — understanding your 10-year fracture risk helps you understand your treatment plan
• Ask which risk category you fall into — very high, high, moderate, or low
• Make sure your treatment matches your risk level — if you are at very high risk, ask about bone-building medications
• Do not skip the basics — calcium, vitamin D, exercise, and fall prevention are part of every guideline
• If you have had a fracture and are not on treatment, ask why not
• Keep up with follow-up appointments — guidelines recommend periodic reassessment of your bone health

Q: Do I need to understand all these different guidelines? A: No. Your doctor will apply the guidelines that are most relevant to your country and healthcare system. What is important for you is understanding the general principles: treat fracture risk (not just bone density), take your medication as prescribed, and combine it with lifestyle measures.

Q: My T-score is -2.0 (osteopenia). Do I need medication? A: It depends on your overall fracture risk. If your FRAX score exceeds the treatment threshold for your country, or if you have other significant risk factors, your doctor may recommend medication even with a T-score in the osteopenia range. If your overall risk is low, lifestyle measures and monitoring may be sufficient.

Q: Are the guidelines the same everywhere in the world? A: The core principles are similar, but specific thresholds and available treatments vary by country. This reflects differences in healthcare systems, population fracture rates, and available resources. The important thing is that you are receiving evidence-based care.

Q: How often should guidelines be updated? A: Major guidelines are typically updated every 3 to 5 years, or sooner if important new evidence emerges. Your doctor stays current with these updates to ensure your care reflects the latest evidence.

Q: Can I access FRAX myself? A: Yes. The FRAX calculator is freely available at frax.shef.ac.uk. You can enter your own information, although having your bone density value makes the estimate more accurate. Discuss the results with your doctor.

• Kanis JA, et al. European Guidance for the Diagnosis and Management of Osteoporosis in Postmenopausal Women (IOF/ESCEO). Osteoporos Int. 2019;30(1):3-44.
• National Osteoporosis Foundation (NOF). Clinician's Guide to Prevention and Treatment of Osteoporosis. 2021.
• Camacho PM, et al. American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2020 Update. Endocr Pract. 2020;26(Suppl 1):1-46.
• NICE Technology Appraisal Guidance. Bisphosphonates for Treating Osteoporosis (TA464). 2017. Romosozumab for Treating Severe Osteoporosis (TA791). 2022.
• Royal Australian College of General Practitioners (RACGP). Osteoporosis Prevention, Diagnosis and Management in Postmenopausal Women and Men Over 50 Years of Age. 2nd Edition. 2017.
• World Health Organization (WHO). Assessment of Fracture Risk and Its Application to Screening for Postmenopausal Osteoporosis. WHO Technical Report Series 843. 1994.

This site receives founding sponsorship from [sponsor placeholder]. Article content is independently produced by the editorial team with no sponsor involvement. See our conflict of interest policy for details.